1,650 followers
Efficacy of the dual PI3K and mTOR inhibitor NVP-BEZ235 in combination with imatinib mesylate against chronic… https://t.co/4VhqbNNlJk https://t.co/9waaB4gt49
Efficacy of the dual PI3K and mTOR inhibitor NVP-BEZ235 in combination with imatinib mesylate against chronic… https://t.co/4VhqbNNlJk https://t.co/9waaB4gt49
Efficacy of the dual PI3K & mTOR #inhibitor..against chronic myelogenous leukemia cell lines https://t.co/ZaMjCF4XyC #kinase #cancerresearch